American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules

Journal of Endocrinological Investigation

Volumn 33, Issue 5 SUPPL., 2010, Pages 1-50

  Gharib, Hossein ^a   Papini, Enrico ^a   Paschke, Ralf ^a   Duick, Daniel S ^a   Valcavi, Roberto ^a   Hegedüs, Laszlo ^a   Vitti, Paolo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CALCITONIN; LEVOTHYROXINE; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN;

ABLATION THERAPY; ASPIRATION BIOPSY; CLINICAL PRACTICE; ELASTOGRAPHY; GOITER; HEALTH CARE PERSONNEL; HUMAN; LIOTHYRONINE BLOOD LEVEL; NEEDLE BIOPSY; PRACTICE GUIDELINE; REVIEW; THYROID CANCER; THYROID NODULE; THYROID SCINTISCANNING; THYROIDITIS; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; ULTRASOUND;

BIOPSY, FINE-NEEDLE; FEMALE; HUMANS; IODINE RADIOISOTOPES; THYROID FUNCTION TESTS; THYROID HORMONES; THYROID NEOPLASMS; THYROID NODULE; THYROXINE;

EID: 77954205447     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: None     Document Type: Review

References (214)

1. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: The Whickham survey. Clin Endocrinol (Oxf) 1977, 7: 481-93. [EL 2] (Pubitemid 8235965)
2. Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med 2004, 351: 1764-71. [EL 4 - review]
3. Ross DS. Diagnostic approach to and treatment of thyroid nodules. I. In: Rose BD, ed. UpToDate. Wellesley, MA: UpToDate. Last accessed December 2008. [EL 4 - review]
4. Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 1955, 15: 1270-80. [EL 3]
5. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas: Prevalence by palpation and ultrasonography. Arch Intern Med 1994, 154: 1838-40. [EL 2]
6. Tan GH, Gharib H. Thyroid incidentalomas: Management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997, 126: 226-31. [EL 4]
7. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules: Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 1968, 69: 537-40. [EL 3]
8. Gharib H, Papini E. Thyroid nodules: Clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am 2007, 36: 707-35. [EL 4 - review]
9. Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. Washington DC: Armed Forces Institute of Pathology, c1992. [EL 4]
10. Belfiore A, Giuffrida D, La Rosa GL, et al. High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol (Copenh) 1989, 121: 197-202. [EL 3]
11. Aghini-Lombardi F, Antonangeli L, Martino E, et al. The spectrum of thyroid disorders in an iodine-deficient community: The Pescopagano survey. J Clin Endocrinol Metab 1999, 84: 561-6. [EL 2]
12. Loh KC. Familial nonmedullary thyroid carcinoma: A meta-review of case series. Thyroid 1997, 7: 107-13. [EL 2]
13. Punales MK, da Rocha AP, Meotti C, Gross JL, Maia AL. Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A. Thyroid 2008, 18: 1261-8. [EL 2]
14. Rosenbaum MA, McHenry CR. Contemporary management of papillary carcinoma of the thyroid gland. Expert Rev Anticancer Ther 2009, 9: 317-29. [EL 4 - review]
15. Corrias A, Einaudi S, Chiorboli E, et al. Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: Comparison with conventional clinical, laboratory, and imaging approaches. J Clin Endocrinol Metab 2001, 86: 4644-8. [EL 3]
16. Gough J, Scott-Coombes D, Fausto Palazzo F. Thyroid incidentaloma: An evidence-based assessment of management strategy. World J Surg 2008, 32: 1264-8. [EL 4]
17. Christensen SB, Bondeson L, Ericsson UB, Lindholm K. Prediction of malignancy in the solitary thyroid nodule by physical examination, thyroid scan, fine-needle biopsy and serum thyroglobulin: A prospective study of 100 surgically treated patients. Acta Chir Scand 1984, 150: 433-9. [EL 3]
18. Hamburger JI, Husain M. Contribution of intraoperative pathology evaluation to surgical management of thyroid nodules. Endocrinol Metab Clin North Am 1990, 19: 509-22. [EL 4]
19. Hamming JF, Goslings BM, van Steenis GJ, van Ravenswaay Claasen H, Hermans J, van de Velde CJ. The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds [erratum in: Arch Intern Med 1990, 150: 1088]. Arch Intern Med 1990, 150: 113-6. [EL 3]
20. Papini E. The dilemma of non-palpable thyroid nodules. J Endocrinol Invest 2003, 26: 3-4. [EL 4 - editorial] (Pubitemid 36292245)
21. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002, 87: 1941-6. [EL 3]
22. Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: Relevance of iodine intake, sex, age, and multinodularity. Am J Med 1992, 93: 363-9. [EL 3]
23. Tan GH, Gharib H, Reading CC. Solitary thyroid nodule: Comparison between palpation and ultrasonography. Arch Intern Med 1995, 155: 2418-23. [EL 3]
24. Jarlov AE, Nygaard B, Hegedus L, Hartling SG, Hansen JM. Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter. Thyroid 1998, 8: 393-8. [EL 3]
25. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006, 91: 4295-301. [EL 3]
26. Ashcraft MW, Van Herle AJ. Management of thyroid nodules. II: Scanning techniques, thyroid suppressive therapy, and fine needle aspiration. Head Neck Surg 1981, 3: 297-322. [EL 4 - review]
27. Yano Y, Shibuya H, Kitagawa W, et al. Recent outcome of Graves' disease patients with papillary thyroid cancer. Eur J Endocrinol 2007, 157: 325-9. [EL 3]
28. Shetty SK, Maher MM, Hahn PF, Halpem EF, Aquino SL. Significance of incidental thyroid lesions detected on CT: Correlation among CT, sonography, and pathology [erratum in: AJR Am J Roentgenol 2007, 188: 8]. AJR Am J Roentgenol 2006, 187: 1349-56. [EL 3]
29. Razek AA, Sadek AG, Kombar OR, Elmahdy TE, Nada N. Role of apparent diffusion coefficient values in differentiation between malignant and benign solitary thyroid nodules. AJNR Am J Neuroradiol 2008, 29: 563-8. [EL 3]
30. Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR. FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol 2007, 14: 239-47. [EL 3]
31. Choi JY, Lee KS, Kim HJ, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: Clinical significance and improved characterization. J Nucl Med 2006, 47: 609-15. [EL 3]
32. Hurtado-Lopez LM, Arellano-Montano S, Torres-Acosta EM, et al. Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur J Nucl Med Mol Imaging 2004, 31: 1273-9. [EL 3]
33. Baskin HJ. Ultrasound of thyroid nodules. In: Baskin HJ, ed. Thyroid Ultrasound and Ultrasound-Guided FNA Biopsy. Boston, MA: Kluwer Academic Publishers, 2000: 71-86. [EL 4 - review]
34. Solbiati L, Osti V, Cova L, Tonolini M. Ultrasound of thyroid, parathyroid glands and neck lymph nodes. Eur Radiol 2001, 11: 2411-24. [EL 4 - review]
35. Ahuja A, Ying M. Sonography of neck lymph nodes. Part II: abnormal lymph nodes. Clin Radiol 2003, 58: 359-66. [EL 4 - review]
36. Frates MC, Benson CB, Doubilet PM, et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 2006, 91: 3411-7. [EL 3]
37. Mandel SJ. Diagnostic use of ultrasonography in patients with nodular thyroid disease. Endocr Pract 2004, 10: 246-52. [EL 4 - review]
38. Moon WJ, Jung SL, Lee JH, et al; Thyroid Study Group, Korean Society of Neuro- and Head and Neck Radiology. Benign and malignant thyroid nodules: US differentiation: Multicenter retrospective study. Radiology 2008, 247: 762-70. [EL 3]
39. Kim EK, Park CS, Chung WY, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol 2002, 178: 687-91. [EL 2]
40. Cappelli C, Castellano M, Pirola I, et al. Thyroid nodule shape suggests malignancy. Eur J Endocrinol 2006, 155: 27-31. [EL 3]
41. Horvath E, Majlis S, Rossi R, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab 2009, 94: 1748-51. [EL 2]
42. rd. Management of the thyroid nodule. Head Neck 1989, 11: 414-25. [EL 4]
43. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 2003, 97: 90-6. [EL 3] (Pubitemid 36033867)
44. Leenhardt L, Hejblum G, Franc B, et al. Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab 1999, 84: 24-8. [EL 3]
45. Hagag P, Strauss S, Weiss M. Role of ultrasoundguided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules. Thyroid 1998, 8: 989-95. [EL 3]
46. Cochand-Priollet B, Guillausseau PJ, Chagnon S, et al. The diagnostic value of fine-needle aspiration biopsy under ultrasonography in nonfunctional thyroid nodules: A prospective study comparing cytologic and histologic findings [erratum in: Am J Med 1994, 97: 311]. Am J Med 1994, 97: 152-7. [EL 3]
47. Roti E, degli Uberti EC, Bondanelli M, Braverman LE. Thyroid papillary microcarcinoma: A descriptive and meta-analysis study. Eur J Endocrinol 2008, 159: 659-73. [EL 4 - review]
48. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003, 13: 381-7. [EL 3]
49. Verburg FA, Mader U, Luster M, Reiners C. Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 2009, 71: 291-7. [EL 3]
50. Asteria C, Giovanardi A, Pizzocaro A, et al. US-elastography in the differential diagnosis of benign and malignant thyroid nodules. Thyroid 2008, 18: 523-31. [EL 2]
51. Tranquart F, Bleuzen A, Pierre-Renoult P, Chabrolle C, Sam Giao M, Lecomte P. Elastosonography of thyroid lesions [article in French]. J Radiol 2008, 89: 35-9. [EL 3]
52. Rago T, Santini F, Scutari M, Pinchera A, Vitti P. Elastography: New developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab 2007, 92: 2917-22. [EL 3]
53. Cosgrove D. Future prospects for SonoVue and CPS. Eur Radiol 2004, 14 (Suppl 8): P116-24. [EL 4]
54. Papini E, Bizzarri G, Pacella CM. Percutaneous laser ablation of benign and malignant thyroid nodules. Curr Opin Endocrinol Diabetes Obes 2008, 15: 434-9. [EL 4 - review]
55. Weber AL, Randolph G, Aksoy FG. The thyroid and parathyroid glands: CT and MR imaging and correlation with pathology and clinical findings. Radiol Clin North Am 2000, 38: 1105-29. [EL 4 - review]
56. Wu HH, Jones JN, Osman J. Fine-needle aspiration cytology of the thyroid: Ten years experience in a community teaching hospital. Diagn Cytopathol 2006, 34: 93-6. [EL 3] (Pubitemid 43201558)
57. DeMay RM. Thyroid. In: The Art and Science of Cytopathology. Vol II: Aspiration Cytology. Chicago, IL: ASCP Press. 1996, 703-78. [EL 4]
58. Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations. Cancer 2007, 111: 306-15. [EL 3]
59. Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid 1998, 8: 15-21. [EL 4]
60. Deandrea M, Mormile A, Veglio M, et al. Fine-needle aspiration biopsy of the thyroid: comparison between thyroid palpation and ultrasonography. Endocr Pract 2002, 8: 282-6. [EL 3]
61. Can AS, Peker K. Comparison of palpation-versus ultrasound-guided fine-needle aspiration biopsies in the evaluation of thyroid nodules. BMC Res Notes 2008, 1: 12. [EL 4]
62. British Thyroid Association. Guidelines for the management of thyroid cancer in adults. London: Royal College of Physicians of London and the British Thyroid Association, 2002 [cited December 1, 2005]. Available at: http://www.british-thyroid-association.org/complete%20guidelines.pdf. [EL 4 - guidelines]
63. European Federation of Cytology Societies. EFCS; 2007-2009. Fadda G. SIAPEC consensus review [written February 27, 2009; cited June 2009]. Available at: www.efes.eu. [EL 4 - consensus]
64. Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008, 36: 425-37. [EL 4 - consensus]
65. Redman R, Zalaznick H, Mazzaferri EL, Massoll NA. The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules. Thyroid 2006, 16: 55-60. [EL 3]
66. Kini SR. Specimen adequacy and assessment, reporting system. In: Thyroid Cytopathology: An Atlas and Text. Philadelphia, PA: Lippincott Williams & Wilkins. 2008, 17-26. [EL 4]
67. Goellner JR, Gharib H, Grant CS, Johnson DA. Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol 1987, 31: 587-90. [EL 3]
68. Cersosimo E, Gharib H, Suman VJ, Goellner JR. "Suspicious" thyroid cytologic findings: outcome in patients without immediate surgical treatment. Mayo Clin Proc 1993, 68: 343-8. [EL 3]
69. Gharib H, Goellner JR. Fine-needle aspiration biopsy of thyroid nodules. Endocr Pract 1995, 1: 410-7. [EL 4]
70. Caruso D, Mazzaferri EL. Fine needle aspiration biopsy in the management of thyroid nodules. Endocrinologist. 1991, 1: 194-202. [EL 4]
71. rd, Goellner JR, Zinsmeister AR. Fine-needle aspiration biopsy of thyroid nodules: impact on thyroid practice and cost of care. Am J Med 1982, 73: 381-4. [EL 3]
72. Hamburger JI, Hamburger SW. Fine needle biopsy of thyroid nodules: avoiding the pitfalls. N Y State J Med 1986, 86:241-9. [EL 4]
73. Pisani T, Bononi M, Nagar C, Angelini M, Bezzi M, Vecchione A. Fine needle aspiration and core needle biopsy techniques in the diagnosis of nodular thyroid pathologies. Anticancer Res 2000, 20: 3843-7. [EL 4]
74. Renshaw AA, Pinnar N. Comparison of thyroid fine-needle aspiration and core needle biopsy. Am J Clin Pathol 2007, 128: 370-4. [EL 3]
75. Zhang S, Ivanovic M, Nemcek AA Jr, Defrias DV, Lucas E, Nayar R. Thin core needle biopsy crush preparations in conjunction with fine-needle aspiration for the evaluation of thyroid nodules: a complementary approach. Cancer 2008, 114: 512-8. [EL 3]
76. Elsheikh TM, Singh HK, Silverman JF. Fine-needle aspiration cytology versus core needle biopsy in the evaluation of thyroid and salivary gland lesions. Path Case Rev 2007, 12:3-9. [EL 4]
77. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem 1996, 42: 140-5. [EL 4 - review]
78. Baloch Z, Carayon P, Conte-Devolx B, et al; Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines: Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13: 3-126. [EL 4 - guidelines]
79. Ross DS. Laboratory assessment of thyroid dysfunction. In: Rose BD, ed. UpToDate. Wellesley, MA: UpToDate, 2005. [EL 4 - review]
80. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: Current status and future perspectives. Endocr Rev 2003, 24: 102-32. [EL 4 - review] (Pubitemid 36223282)
81. Carle A, Pedersen IB, Knudsen N, et al. Thyroid volume in hypothyroidism due to autoimmune disease follows a unimodal distribution: Evidence against primary thyroid atrophy and autoimmune thyroiditis being distinct diseases. J Clin Endocrinol Metab 2009, 94: 833-9. [EL 3]
82. Wallaschofski H, Orda C, Georgi P, Miehle K, Paschke R. Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter. Horm Metab Res 2001, 33: 504-7. [EL 3]
83. Pedersen IB, Knudsen N, Perrild H, Ovesen L, Laurberg P. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: A comparison of two competitive binding assays. Clin Endocrinol (Oxf) 2001, 55: 381-90. [EL 3]
84. Date J, Feldt-Rasmussen U, Blichert-Toft M, Hegedus L, Graversen HP. Long-term observation of serum thyroglobulin after resection of nontoxic goiter and relation to ultrasonographically demonstrated relapse. World J Surg 1996, 20: 351-6. [EL 3]
85. Giovanella L, Ceriani L, Ghelfo A, Maffioli M, Keller F. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy. Clin Endocrinol (Oxf) 2007, 67: 547-51. [EL 3]
86. Cohen R, Campos JM, Salaun C, et al; Groupe d'Etudes des Tumeurs a Calcitonine (GETC). Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. J Clin Endocrinol Metab 2000, 85: 919-22. [EL 3]
87. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86: 5658-71. [EL 3 - guidelines]
88. Elisei R, Bottici V, Luchetti F, et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: Experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 2004, 89: 163-8. [EL 3]
89. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B. Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 1997, 82: 1589-93. [EL 3]
90. Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab 2008, 93: 2173-80. [EL 3]
91. Niccoli P, Wion-Barbot N, Caron P, et al; The French Medullary Study Group. Interest of routine measurement of serum calcitonin: Study in a large series of thyroidectomized patients. J Clin Endocrinol Metab 1997, 82: 338-41. [EL 3]
92. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 2007, 92: 450-5. [EL 2]
93. d'Herbomez M, Caron P, Bauters C, et al; French Group GTE (Groupe des Tumeurs Endocrines). Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking. Eur J Endocrinol 2007, 157: 749-55. [EL 3]
94. Kotzmann H, Schmidt A, Scheuba C, et al. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma. Thyroid 1999, 9: 943-7. [EL 3]
95. Erdogan MF, Gullu S, Baskal N, Uysal AR, Kamel N, Erdogan G. Omeprazole: Calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma. J Clin Endocrinol Metab 1997, 82: 897-9. [EL 3]
96. Karges W, Dralle H, Raue F, et al; German Society for Endocrinology (DGE) - Thyroid Section. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 2004, 112: 52-8. [EL 3]
97. Doyle P, Duren C, Nerlich K, et al. Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults [erratum in: J Clin Endocrinol Metab 2009, 94: 4629]. J Clin Endocrinol Metab 2009, 94: 2970-4. [EL 2]
98. de Groot JW, Links TP, Plukker JT, Lips CJ, Hofstra RM. RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocr Rev 2006, 27: 535-60. [EL 4]
99. Wohllk N, Cote GJ, Bugalho MM, et al. Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 1996, 81: 3740-5. [EL 3]
100. Meller J, Becker W. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. Eur J Nucl Med Mol Imaging 2002, 29 (Suppl 2): S425-38. [EL 3]
101. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: An appraisal. Ann Intern Med 1993, 118: 282-9. [EL 4] (Pubitemid 23046388)
102. La Rosa GL, Belfiore A, Giuffrida D, et al. Evaluation of the fine needle aspiration biopsy in the preoperative selection of cold thyroid nodules. Cancer 1991, 67: 2137-41. [EL 3]
103. Slowinska-Klencka D, Klencki M, Sporny S, Lewinski A. Fine-needle aspiration biopsy of the thyroid in an area of endemic goitre: Influence of restored sufficient iodine supplementation on the clinical significance of cytological results. Eur J Endocrinol 2002, 146: 19-26. [EL 3] (Pubitemid 34126414)
104. Knudsen N, Perrild H, Christiansen E, Rasmussen S, Dige-Petersen H, Jorgensen T. Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol 2000, 142: 224-30. [EL 3]
105. Belfiore A, La Rosa GL, Padova G, Sava L, Ippolito O, Vigneri R. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodinedeficient area. Cancer 1987, 60: 3096-102. [EL 3]
106. McHenry CR, Slusarczyk SJ, Askari AT, et al. Refined use of scintigraphy in the evaluation of nodular thyroid disease. Surgery 1998, 124: 656-61. [EL 3]
107. Meier DA, Kaplan MM. Radioiodine uptake and thyroid scintiscanning. Endocrinol Metab Clin North Am 2001, 30: 291-313. [EL 4 - review]
108. Bonnema SJ, Bennedbaek FN, Hegedus L. Danish endocrinologists' examination and treatment of nontoxic multinodular goiter: a questionnaire study [article in Danish]. Ugeskr Laeger 2001, 163: 1265-9. [EL 3]
109. Hillenhinrichs H, Emrich D. Euthyroid goiter with and without functional autonomy in the euthyroid phase: a comparison [article in German]. Nuklearmedizin 1998, 37: 95-100. [EL 3]
110. Tollin SR, Fallon EF, Mikhail M, Goldstein H, Yung E. The utility of thyroid nuclear imaging and other studies in the detection and treatment of underlying thyroid abnormalities in patients with endogenous subclinical thyrotoxicosis. Clin Nucl Med 2000, 25: 341-7. [EL 3]
111. Krohn K, Wohlgemuth S, Gerber H, Paschke R. Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations. J Pathol 2000, 192: 37-42. [EL 3]
112. Kwak JY, Kim EK, Kim HJ, Kim MJ, Son EJ, Moon HJ. How to combine ultrasound and cytological information in decision making about thyroid nodules. Eur Radiol 2009, 19: 1923-31. [EL 3]
113. McHenry CR, Walfish PG, Rosen IB. Non-diagnostic fine needle aspiration biopsy: a dilemma in management of nodular thyroid disease. Am Surg 1993, 59: 415-9. [EL 3]
114. Schmidt T, Riggs MW, Speights VO Jr. Significance of nondiagnostic fine-needle aspiration of the thyroid. South Med J 1997, 90: 1183-6. [EL 3] (Pubitemid 27528355)
115. MacDonald L, Yazdi HM. Nondiagnostic fine needle aspiration biopsy of the thyroid gland: a diagnostic dilemma. Acta Cytol 1996, 40: 423-8. [EL 3] (Pubitemid 26189670)
116. Cappelli C, Pirola I, Castellano M, et al. Fine needle cytology of complex thyroid nodules. Eur J Endocrinol 2007, 157: 529-32. [EL 3]
117. Orlandi A, Puscar A, Capriata E, Fideleff H. Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: Critical evaluation of long-term follow-up. Thyroid 2005, 15: 274-8. [EL 3]
118. Gallo M, Pesenti M, Valcavi R. Ultrasound thyroid nodule measurements: the "gold standard" and its limitations in clinical decision making. Endocr Pract 2003, 9: 194-9. [EL 4 - review]
119. Menendez Torre E, Pineda Arribas J, Martinez de Esteban JP, et al. Value of repeated fine needle aspiration cytology in patients with nodular goiter. Acta Cytol 2007, 51: 850-2. [EL 3]
120. Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA. Suppressive therapy with levothyroxine for solitary thyroid nodules: A double-blind controlled clinical study. N Engl J Med 1987, 317: 70-5. [EL 1] (Pubitemid 17093734)
121. La Rosa GL, Ippolito AM, Lupo L, et al. Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics. J Clin Endocrinol Metab 1996, 81: 4385-7. [EL 2]
122. Papini E, Petrucci L, Guglielmi R, et al. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 1998, 83: 780-3. [EL 1]
123. Wemeau JL, Caron P, Schvartz C, et al. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 2002, 87: 4928-34. [EL 1]
124. Hegedus L, Nygaard B, Hansen JM. Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified? J Clin Endocrinol Metab 1999, 84:756-60. [EL 2]
125. Moalem J, Suh I, Duh QY. Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature. World J Surg 2008, 32: 1301-12. [EL 4]
126. Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 1994, 130: 350-6. [EL 1]
127. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: A meta-analysis. J Clin Endocrinol Metab 1996, 81: 4278-89. [EL 1]
128. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994, 331: 1249-52. [EL 2]
129. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: A 10-year cohort study. Lancet 2001, 358: 861-5. [EL 2] (Pubitemid 32900566)
130. La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 1995, 122: 1-8. [EL 2]
131. Miccoli P, Minuto MN, Ugolini C, Pisano R, Fosso A, Berti P. Minimally invasive video-assisted thyroidectomy for benign thyroid disease: An evidence-based review. World J Surg 2008, 32: 1333-40. [EL 4 - review]
132. Alvarado R, McMullen T, Sidhu SB, Delbridge LW, Sywak MS. Minimally invasive thyroid surgery for single nodules: an evidence-based review of the lateral mini-incision technique. World J Surg 2008, 32: 1341-8. [EL 4 - review]
133. Livraghi T, Paracchi A, Ferrari C, et al. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results: work in progress. Radiology 1990, 175: 827-9. [EL 4]
134. Pacella CM, Bizzarri G, Guglielmi R, et al. Thyroid tissue: US-guided percutaneous interstitial laser ablation: a feasibility study. Radiology 2000, 217: 673-7. [EL 3]
135. Verde G, Papini E, Pacella CM, et al. Ultrasound guided percutaneous ethanol injection in the treatment of cystic thyroid nodules. Clin Endocrinol (Oxf) 1994, 41: 719-24. [EL 1]
136. Guglielmi R, Pacella CM, Bianchini A, et al. Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid 2004, 14: 125-31. [EL 2]
137. Valcavi R, Frasoldati A. Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules. Endocr Pract 2004,10: 269-75. [EL 3]
138. Kim JH, Lee HK, Lee JH, Ahn IM, Choi CG. Efficacy of sonographically guided percutaneous ethanol injection for treatment of thyroid cysts versus solid thyroid nodules. AJR Am J Roentgenol 2003, 180: 1723-6. [EL 3]
139. Zingrillo M, Torlontano M, Chiarella R, et al. Percutaneous ethanol injection may be a definitive treatment for symptomatic thyroid cystic nodules not treatable by surgery: Five-year follow-up study. Thyroid 1999, 9: 763-7. [EL 3]
140. Bennedbaek FN, Hegedus L. Treatment of recurrent thyroid cysts with ethanol: A randomized double-blind controlled trial. J Clin Endocrinol Metab 2003, 88: 5773-7. [EL 1]
141. Lippi F, Ferrari C, Manetti L, et al; the Multicenter Study Group. Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: Results of an Italian multicenter study. J Clin Endocrinol Metab 1996, 81: 3261-4. [EL 3]
142. Livraghi T, Paracchi A, Ferrari C, Reschini E, Macchi RM, Bonifacino A. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: 4-year experience. Radiology 1994, 190: 529-33. [EL 3]
143. Zingrillo M, Collura D, Ghiggi MR, Nirchio V, Trischitta V. Treatment of large cold benign thyroid nodules not eligible for surgery with percutaneous ethanol injection. J Clin Endocrinol Metab 1998, 83: 3905-7. [EL 3]
144. Bennedbaek FN, Nielsen LK, Hegedus L. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: A randomized trial. J Clin Endocrinol Metab 1998, 83: 830-5. [EL 1] (Pubitemid 28496454)
145. Kim YS, Rhim H, Tae K, Park DW, Kim ST. Radiofrequency ablation of benign cold thyroid nodules: Initial clinical experience. Thyroid 2006, 16: 361-7. [EL 4]
146. Spiezia S, Garberoglio R, Milone F, et al. Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid 2009, 19: 219-25. [EL 3]
147. Dossing H, Bennedbaek FN, Hegedus L. Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules: One versus three treatments. Thyroid 2006, 16: 763-8. [EL 3]
148. Dossing H, Bennedbaek FN, Hegedus L. Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules: A randomised study. Eur J Endocrinol 2005, 152: 341-5. [EL 2]
149. Papini E, Guglielmi R, Bizzarri G, et al. Treatment of benign cold thyroid nodules: A randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up. Thyroid 2007, 17: 229-35. [EL 1]
150. Cakir B, Ugras NS, Gul K, Ersoy R, Korukluoglu B. Initial report of the results of percutaneous laser ablation of benign cold thyroid nodules: Evaluation of histopathological changes after 2 years. Endocr Pathol 2009, 20: 170-6. [EL 3]
151. Meier DA, Brill DR, Becker DV, et al; Society of Nuclear Medicine. Procedure guideline for therapy of thyroid disease with (131)iodine. J Nucl Med 2002, 43: 856-61. [EL 3 - guidelines]
152. Nygaard B, Hegedus L, Nielsen KG, Ulriksen P, Hansen JM. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol (Oxf) 1999, 50: 197-202. [EL 3]
153. Dietlein M, Dressier J, Grunwald F, et al; Deutsche Gesellschaft für Nuklearmedizin. Guideline for radioiodine therapy for benign thyroid diseases (version 4) [article in German]. Nuklearmedizin 2007, 46: 220-3. [EL 4 - guidelines]
154. Reiners C, Schneider P. Radioiodine therapy of thyroid autonomy. Eur J Nucl Med Mol Imaging 2002, 29 (Suppl 2): S471-8. [EL 3]
155. Metso S, Jaatinen P, Huhtala H, Auvinen A, Oksala H, Salmi J. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism [erratum in: J Clin Endocrinol Metab 2007, 92: 4008]. J Clin Endocrinol Metab 2007, 92: 2190-6. [EL 2]
156. Ron E, Doody MM, Becker DV, et al; Cooperative Thyrotoxicosis Therapy Follow-up Study Group. Cancer mortality following treatment for adult hyperthyroidism. JAMA 1998, 280: 347-55. [EL 3]
157. Ceccarelli C, Bencivelli W, Vitti P, Grasso L, Pinchera A. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: A 20 years' retrospective study. Clin Endocrinol (Oxf) 2005, 62: 331-5. [EL 3]
158. Nygaard B, Faber J, Veje A, Hegedis L, Hansen JM. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 1311 therapy. Thyroid 1999, 9: 477-81. [EL 3]
159. Nygaard B, Knudsen JH, Hegedus L, Scient AV, Hansen JE. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 1311 treatment in patients with nontoxic goiter. J Clin Endocrinol Metab 1997, 82: 2926-30. [EL 3]
160. Wallaschofski H, Muller D, Georgi P, Paschke R. Induction of TSH-receptor antibodies in patients with toxic multinodular goitre by radioiodine treatment. Horm Metab Res 2002, 34: 36-9. [EL 3]
161. Vos XG, Smit N, Endert E, Brosschot JF, Tijssen JG, Wiersinga WM. Age and stress as determinants of the severity of hyperthyroidism caused by Graves' disease in newly diagnosed patients. Eur J Endocrinol 2009, 160: 193-9. [EL 3]
162. Bonnema SJ, Bennedbaek FN, Veje A, Marving J, Hegedus L. Propylthiouracil before 1311 therapy of hyperthyroid diseases: effect on cure rate evaluated by
163. Walter MA, Briel M, Christ-Crain M, et al. Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. BMJ 2007, 334: 514. [EL 1]
164. Weetman AP. Radioiodine treatment for benign thyroid diseases. Clin Endocrinol (Oxf) 2007, 66: 757-64. [EL 4 - review]
165. Hegedus L, Hansen BM, Knudsen N, Hansen JM. Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. BMJ 1988, 297: 661-2. [EL 3]
166. Nygaard B, Hegedus L, Gervil M, Hjalgrim H, Soe-Jensen P, Hansen JM. Radioiodine treatment of multinodular non-toxic goitre. BMJ 1993, 307: 828-32. [EL 3]
167. Huysmans DA, Hermus AR, Corstens FH, Barentsz JO, Kloppenborg PW. Large, compressive goiters treated with radioiodine. Ann Intern Med 1994, 121: 757-62. [EL 3]
168. de Klerk JM, van Isselt JW, van Dijk A, et al. Iodine-131 therapy in sporadic nontoxic goiter. J Nucl Med 1997, 38: 372-6. [EL 3]
169. Fast S, Nielsen VE, Bonnema SJ, Hegedus L. Time to reconsider nonsurgical therapy of benign nontoxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy. Eur J Endocrinol 2009, 160: 517-28. [EL 4 - review]
170. Wesche MF, Tiel-V Buul MM, Lips P, Smits NJ, Wiersinga WM. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 2001, 86: 998-1005. [EL 1]
171. Bonnema SJ, Bertelsen H, Mortensen J, et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: Effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 1999, 84: 3636-41. [EL 4]
172. Jarlov AE, Hegedus L, Kristensen LO, Nygaard B, Hansen JM. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? Clin Endocrinol (Oxf) 1995, 43: 325-9. [EL 3]
173. Nielsen VE, Bonnema SJ, Hegedus L. The effects of recombinant human thyrotropin, in normal subjects and patients with goitre. Clin Endocrinol (Oxf) 2004, 61: 655-63. [EL 4 - review]
174. Nielsen VE, Bonnema SJ, Boel-Jorgensen H, Grupe P, Hegedus L. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial. Arch Intern Med 2006, 166: 1476-82. [EL 1]
175. Silva MN, Rubio IG, Romao R, et al. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf) 2004, 60: 300-8. [EL 3]
176. Nieuwlaat WA, Huysmans DA, van den Bosch HC, et al. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 2003, 88: 3121-9. [EL 3]
177. Barca MF, Gruppi C, Oliveira MT, et al. Cardiovascular assessment of hyperthyroid patients with multinodular goiter before and after radioiodine treatment preceded by stimulation with recombinant human TSH. Endocrine 2007, 32: 175-81. [EL 3]
178. Nielsen VE, Bonnema SJ, Hegedus L. Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial. J Clin Endocrinol Metab 2006, 91: 1317-22. [EL 1]
179. Pena S, Arum S, Cross M, et al. 123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers. J Clin Endocrinol Metab 2006, 91: 506-10. [EL 3]
180. Castro MR, Gharib H. Continuing controversies in the management of thyroid nodules. Ann Intern Med 2005, 142: 926-31. [EL 4]
181. Schlinkert RT, van Heerden JA, Goellner JR, et al. Factors that predict malignant thyroid lesions when fine-needle aspiration is "suspicious for follicular neoplasm". Mayo Clin Proc 1997, 72: 913-6. [EL 3]
182. Bartolazzi A, Orlandi F, Saggiorato E, et al; Italian Thyroid Cancer Study Group (ITCSG). Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol 2008, 9: 543-9. [EL 2]
183. Salvatore G, Giannini R, Faviana P, et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 2004, 89: 5175-80. [EL 2]
184. Yassa L, Cibas ES, Benson CB, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 2007, 111: 508-16. [EL 2]
185. Haymart MR, Greenblatt DY, Elson DF, Chen H. The role of intraoperative frozen section if suspicious for papillary thyroid cancer. Thyroid 2008, 18: 419-23. [EL 3] (Pubitemid 351519550)
186. Cobin RH, Gharib H, Bergman DA, et al; Thyroid Carcinoma Task Force. AACE/AAES medical/surgical guidelines for clinical practice: Management of thyroid carcinoma [erratum in: Endocr Pract 2008, 14: 802-3]. Endocr Pract 2001, 7: 202-20. [EL 4 - guidelines]
187. Cooper DS, Doherty GM, Haugen BR, et al; American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006, 16: 109-42. [EL 4 - guidelines]
188. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium [erratum in: Eur J Endocrinol 2006, 155: 385]. Eur J Endocrinol 2006, 154: 787-803. [EL 4 - consensus]
189. National Comprehensive Cancer Network. NCCN categories of evidence and consensus [cited March 2009]. Available at: http://www.nccn.org/professionals/ physician-gls/categories-of-consensus.asp. [EL 4 - guidelines]
190. Baloch ZW, Barroeta JE, Walsh J, et al. Utility of thyroglobulin measurement in fine-needle aspiration biopsy specimens of lymph nodes in the diagnosis of recurrent thyroid carcinoma. Cytojournal 2008, 5: 1. [EL 4]
191. Kim E, Park JS, Son KR, Kim JH, Jeon SJ, Na DG. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: Comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid 2008, 18: 411-8. [EL 3]
192. Freudenberg LS, Antoch G, Jentzen W, et al. Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer. Eur Radiol 2004, 14: 2092-8. [EL 3]
193. Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007, 92 (Suppl 8): S1-47. [EL 4 - guidelines]
194. Kung AW, Chau MT, Lao TT, Tam SC, Low LC. The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab 2002, 87: 1010-4. [EL 2]
195. Rosen IB, Korman M, Walfish PG. Thyroid nodular disease in pregnancy: Current diagnosis and management. Clin Obstet Gynecol 1997, 40: 81-9. [EL 4]
196. Marley EF, Oertel YC. Fine-needle aspiration of thyroid lesions in 57 pregnant and postpartum women. Diagn Cytopathol 1997, 16: 122-5. [EL 3]
197. Moosa M, Mazzaferri EL. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab 1997, 82: 2862-6. [EL 3]
198. Rallison ML, Dobyns BM, Keating FR Jr, Rall JE, Tyler FH. Thyroid nodularity in children. JAMA 1975, 233: 1069-72. [EL 4]
199. Hung W. Nodular thyroid disease and thyroid carcinoma. Pediatr Ann 1992, 21: 50-7. [EL 4 - review]
200. Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer 2006, 13: 427-53. [EL 4 - review]
201. Raab SS, Silverman JF, Elsheikh TM, Thomas PA, Wakely PE. Pediatric thyroid nodules: Disease demographics and clinical management as determined by fine needle aspiration biopsy. Pediatrics 1995, 95: 46-9. [EL 3]
202. Amrikachi M, Ponder TB, Wheeler TM, Smith D, Ramzy I. Thyroid fine-needle aspiration biopsy in children and adolescents: experience with 218 aspirates. Diagn Cytopathol 2005, 32: 189-92. [EL 3]
203. Chang SH, Joo M, Kim H. Fine needle aspiration biopsy of thyroid nodules in children and adolescents. J Korean Med Sci 2006, 21: 469-73. [EL 3]
204. Belfiore A, La Rosa GL, Padova G, Sava L, Ippolito O, Vigneri R. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer 1987, 60: 3096-102. [EL 3]
205. Canadian Pediatric Thyroid Nodule (CaPTN) Study Group. The Canadian Pediatric Thyroid Nodule Study: An evaluation of current management practices. J Pediatr Surg 2008, 43: 826-30. [EL 4]
206. Drozd VM, Lushchik ML, Polyanskaya ON, et al. The usual ultrasonographic features of thyroid cancer are less frequent in small tumors that develop after a long latent period after the Chernobyl radiation release accident. Thyroid 2009,19: 725-34. [EL 2]
207. Feinmesser R, Lubin E, Segal K, Noyek A. Carcinoma of the thyroid in children: A review. J Pediatr Endocrinol Metab 1997, 10: 561-8. [EL 4 - review]
208. Alessandri AJ, Goddard KJ, Blair GK, Fryer CJ, Schultz KR. Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma. Med Pediatr Oncol 2000, 35: 41-6. [EL 3]
209. Niedziela M, Breborowicz D, Trejster E, Korman E. Hot nodules in children and adolescents in western Poland from 1996 to 2000: Clinical analysis of 31 patients. J Pediatr Endocrinol Metab 2002, 15: 823-30. [EL 3]
210. Haynes RB, Wilczynski N, McKibbon KA, Walker CJ, Sinclair JC. Developing optimal search strategies for detecting clinically sound studies in MEDLINE. J Am Med Inform Assoc 1994, 1: 447-58. [EL 4]
211. Hunt DL, McKibbon KA. Locating and appraising systematic reviews. Ann Intern Med 1997, 126: 532-8. [EL 4]
212. Mechanick JI, Bergman DA, Braithwaite SS, Palumbo PJ; American Association of Clinical Endocrinologists Ad Hoc Task Force for Standardized Production of Clinical Practice Guidelines. American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines [erratum in: Endocr Pract 2008, 14: 802-3]. Endocr Pract 2004, 10: 353-61. [EL 4 - guidelines]
213. Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract 2008, 14 (Suppl 1): 1-83. [EL 4 - guidelines]
214. Gharib H, Papini E, Paschke R. Thyroid nodules: A review of current guidelines, practices, and prospects. Eur J Endocrinol 2008, 159: 493-505. [EL 4 - review]